1. Home
  2. CDIO vs ULY Comparison

CDIO vs ULY Comparison

Compare CDIO & ULY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDIO
  • ULY
  • Stock Information
  • Founded
  • CDIO 2017
  • ULY 2013
  • Country
  • CDIO United States
  • ULY United States
  • Employees
  • CDIO N/A
  • ULY N/A
  • Industry
  • CDIO Biotechnology: Commercial Physical & Biological Resarch
  • ULY
  • Sector
  • CDIO Health Care
  • ULY
  • Exchange
  • CDIO Nasdaq
  • ULY Nasdaq
  • Market Cap
  • CDIO 6.4M
  • ULY 6.3M
  • IPO Year
  • CDIO N/A
  • ULY N/A
  • Fundamental
  • Price
  • CDIO $3.86
  • ULY $3.99
  • Analyst Decision
  • CDIO
  • ULY Strong Buy
  • Analyst Count
  • CDIO 0
  • ULY 2
  • Target Price
  • CDIO N/A
  • ULY $11.50
  • AVG Volume (30 Days)
  • CDIO 21.5K
  • ULY 89.4K
  • Earning Date
  • CDIO 11-12-2025
  • ULY 11-11-2025
  • Dividend Yield
  • CDIO N/A
  • ULY N/A
  • EPS Growth
  • CDIO N/A
  • ULY N/A
  • EPS
  • CDIO N/A
  • ULY N/A
  • Revenue
  • CDIO $19,507.00
  • ULY $131,235,000.00
  • Revenue This Year
  • CDIO $1,434.82
  • ULY N/A
  • Revenue Next Year
  • CDIO $4,661.91
  • ULY $20.23
  • P/E Ratio
  • CDIO N/A
  • ULY N/A
  • Revenue Growth
  • CDIO N/A
  • ULY N/A
  • 52 Week Low
  • CDIO $3.22
  • ULY $2.99
  • 52 Week High
  • CDIO $53.10
  • ULY $17.99
  • Technical
  • Relative Strength Index (RSI)
  • CDIO 51.46
  • ULY 38.70
  • Support Level
  • CDIO $3.58
  • ULY $3.70
  • Resistance Level
  • CDIO $3.98
  • ULY $4.29
  • Average True Range (ATR)
  • CDIO 0.23
  • ULY 0.39
  • MACD
  • CDIO 0.03
  • ULY 0.05
  • Stochastic Oscillator
  • CDIO 66.67
  • ULY 30.39

About CDIO Cardio Diagnostics Holdings Inc. Common stock

Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.

About ULY Urgent.ly Inc.

Urgently Inc is a connected mobility assistance software platform, matching vehicle owners and operators with service professionals who deliver traditional roadside assistance, proactive maintenance and repair services. The traditional experience of a vehicle breakdown is often stressful and inconvenient, compounded by processes that lack transparency and to long wait times. Urgently offers an alternative to this traditional experience, leveraging its digitally native software platform to match supply and demand in its network and deliver exceptional mobility assistance experiences at scale.

Share on Social Networks: